Ingen Technologies PE Ratio 2011-2013 | IGNT
Current and historical p/e ratio for Ingen Technologies (IGNT) from 2011 to 2013. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ingen Technologies PE ratio as of May 01, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Ingen Technologies PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
0.00 | nan |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.000B | $0.000B |
Ingen Technologies, Inc. develops, markets and distributes medical technologies and products with applications in the respiratory device markets and the medical diagnostics market, as well as markets in emergency response, aviation, military and consumer markets. The Company's products include Oxyview and OxyAlert, which are respiratory products and GasAlert, a commercial consumer product using the same technology as OxyAlert. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters. The company also offers a Secure Balance product, a private-label product that includes a vestibular function testing system and balance therapy system for physicians. Ingen Technologies is based in Yucaipa, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $183.877B | 24.14 |
Stryker (SYK) | United States | $128.028B | 30.70 |
Boston Scientific (BSX) | United States | $107.805B | 33.58 |
Medtronic (MDT) | Ireland | $106.544B | 15.08 |
EssilorLuxottica (ESLOY) | France | $97.060B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.204B | 0.00 |
Haleon (HLN) | United Kingdom | $38.949B | 30.46 |
ResMed (RMD) | United States | $31.437B | 29.52 |
Terumo (TRUMY) | Japan | $25.223B | 35.62 |
Zimmer Biomet Holdings (ZBH) | United States | $24.713B | 15.91 |
Koninklijke Philips (PHG) | Netherlands | $24.656B | 19.10 |
Baxter (BAX) | United States | $20.501B | 14.95 |
Insulet (PODD) | United States | $12.040B | 63.21 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.549B | 0.00 |
Demant (WILYY) | Denmark | $10.525B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.693B | 22.92 |
BellRing Brands (BRBR) | United States | $7.226B | 38.85 |
Haemonetics (HAE) | United States | $4.670B | 23.88 |
Lantheus Holdings (LNTH) | United States | $4.561B | 11.78 |
Perrigo (PRGO) | Ireland | $4.426B | 12.66 |
GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
Prestige Consumer Healthcare (PBH) | United States | $3.563B | 16.84 |
Envista Holdings (NVST) | United States | $3.382B | 12.86 |
Green Thumb Industries (GTBIF) | United States | $3.229B | 102.33 |
QuidelOrtho (QDEL) | United States | $2.712B | 9.84 |
Neogen (NEOG) | United States | $2.671B | 25.69 |
ICU Medical (ICUI) | United States | $2.386B | 17.80 |
Verano Holdings (VRNOF) | United States | $2.161B | 0.00 |
TG Therapeutics (TGTX) | United States | $2.111B | 683.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.061B | 0.00 |
Owens & Minor (OMI) | United States | $1.895B | 18.19 |
Agios Pharmaceuticals (AGIO) | United States | $1.845B | 0.00 |
Canopy Growth (CGC) | Canada | $1.491B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.455B | 48.00 |
InMode (INMD) | Israel | $1.444B | 7.47 |
National Vision Holdings (EYE) | United States | $1.364B | 42.49 |
AdaptHealth (AHCO) | United States | $1.309B | 9.85 |
AtriCure (ATRC) | United States | $1.167B | 0.00 |
Warby Parker (WRBY) | United States | $1.163B | 0.00 |
MacroGenics (MGNX) | United States | $0.925B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.857B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.795B | 0.00 |
Evolus (EOLS) | United States | $0.737B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.676B | 14.65 |
VAREX IMAGING (VREX) | United States | $0.660B | 14.25 |
TerrAscend (TSNDF) | Canada | $0.635B | 0.00 |
Quanterix (QTRX) | United States | $0.617B | 0.00 |
Jin Medical (ZJYL) | China | $0.591B | 0.00 |
Valneva SE (VALN) | France | $0.519B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.503B | 0.00 |
PetIQ (PETQ) | United States | $0.480B | 17.93 |
ZimVie (ZIMV) | United States | $0.414B | 25.33 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.405B | 6.70 |
Surmodics (SRDX) | United States | $0.366B | 39.52 |
Zynex (ZYXI) | United States | $0.353B | 47.70 |
Viemed Healthcare (VMD) | United States | $0.318B | 31.50 |
Cerus (CERS) | United States | $0.309B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.263B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.238B | 14.71 |
Organigram Holdings (OGI) | Canada | $0.219B | 0.00 |
Veru (VERU) | United States | $0.198B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.182B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.171B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.166B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.165B | 83.00 |
Quipt Home Medical (QIPT) | United States | $0.153B | 0.00 |
InterCure (INCR) | Israel | $0.133B | 22.46 |
FitLife Brands (FTLF) | United States | $0.128B | 20.55 |
MariMed (MRMD) | United States | $0.122B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
Fonar (FONR) | United States | $0.100B | 8.55 |
Allurion Technologies (ALUR) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Chimerix (CMRX) | United States | $0.084B | 0.00 |
Safety Shot (SHOT) | United States | $0.075B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.47 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Bright Green (BGXX) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.66 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Flora Growth (FLGC) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.016B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |